⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COSM News
Cosmos Holdings Inc. Common Stock
Artificial Intelligence in Drug Repurposing Global Market Research Report 2025 with Long-term Prospects to 2029 and 2034
globenewswire.com
IBM
EVGN
DNA
RXRX
COSM
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
globenewswire.com
COSM
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
accessnewswire.com
COSM
Cosmos Health is Forcing the Market to Reframe the Conversation
accessnewswire.com
COSM
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
globenewswire.com
COSM
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
globenewswire.com
COSM
Chronic Kidney Disease Anemia Market Opportunity Assessment and Forecasts 2024-2034: Drug Costs, Safety Improvements, ESA Alternatives, and Enhanced Clinical Trial Design
globenewswire.com
AMGN
JNJ
GSK
ABBVIE
AKORN
AVROBIO
BAYER
MERCK
COSM
ROCHE
CHMP
SHP
ASTELLAS
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
globenewswire.com
COSM
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
globenewswire.com
COSM
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
COSM